Merrimack Pharmaceuticals Buy Hold or Sell Recommendation
| MACKDelisted Stock | USD 11.96 0.12 1.01% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Merrimack Pharmaceuticals is 'Not Rated'. The recommendation algorithm takes into account all of Merrimack Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note, we conduct extensive research on individual companies such as Merrimack and provide practical buy, sell, or hold advice based on investors' constraints. Merrimack Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Merrimack |
Execute Merrimack Pharmaceuticals Buy or Sell Advice
The Merrimack recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Merrimack Pharmaceuticals. Macroaxis does not own or have any residual interests in Merrimack Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Merrimack Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Merrimack Pharmaceuticals Trading Alerts and Improvement Suggestions
| Merrimack Pharmaceuticals is not yet fully synchronised with the market data | |
| Merrimack Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (1.18 M) with loss before overhead, payroll, taxes, and interest of (9.1 M). | |
| Merrimack Pharmaceuticals currently holds about 13.36 M in cash with (1.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Merrimack Pharmaceuticals Returns Distribution Density
The distribution of Merrimack Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Merrimack Pharmaceuticals' future price movements. The chart of the probability distribution of Merrimack Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Merrimack Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Merrimack Pharmaceuticals returns is essential to provide solid investment advice for Merrimack Pharmaceuticals.
| Mean Return | -0.05 | Value At Risk | -1.74 | Potential Upside | 1.89 | Standard Deviation | 1.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Merrimack Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Levy Noah G. of 1300 shares of Merrimack Pharmaceuticals at 11.2423 subject to Rule 16b-3 [view details]
Merrimack Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Merrimack . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Merrimack Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Merrimack Pharmaceuticals? Buying financial instruments such as Merrimack Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Merrimack Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |